Cardiac allograft vasculopathy epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
← Older editNewer edit →
VisualWikitext
Aarti Narayan (talk | contribs)
nocaptcha
7,243 edits
Aarti Narayan (talk | contribs)
nocaptcha
7,243 edits
No edit summary
Line 7: Line 7:


==Epidemiology and Demographics==
==Epidemiology and Demographics==
===Donor Demographics and Characteristics===
* In the recent cohort from the ISHLT (International Registry of Heart and Lung Transplant)<ref name="pmid17692781">{{cite journal| author=Taylor DO, Edwards LB, Boucek MM, Trulock EP, Aurora P, Christie J et al.| title=Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult heart transplant report--2007. | journal=J Heart Lung Transplant | year= 2007 | volume= 26 | issue= 8 | pages= 769-81 | pmid=17692781 | doi=10.1016/j.healun.2007.06.004 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17692781  }} </ref>, 69% of the donors are male and the incidence of female donor to male recipient transplantation is seen less frequently than previously.
* Average donor age is 34 years whereas average donor recipient age difference is 16 years.
* The leading cause of donor death was [[head trauma]] (46%) whereas the second most common cause was [[stroke]] (24%). Donor [[diabetes]] and [[hypertension]] is rare but increasing steadily. Average ischemia time was 3.3 hours (range 1.6 to 5.1 hours).
===Recipient Demographics and Characteristics===
* [[Cardiomyopathy]] and [[coronary artery disease]] are the most frequent diagnoses leading to a heart transplant. The proportion of recipients with history of cardiomyopathy is increasing over time.
* Increasing proportions of high risk patients like re-transplants, [[congenital heart diseases]], co-morbidities like [[diabetes mellitus]], [[hypertension]], prior history of [[dialysis]], previous [[malignancy]] and previous [[cardiac surgery]] reflect changes in patient characteristics over time. Also the use of [[left ventricular assist device]]s (LVAD's) in the interim period as a bridge to transplant has increased over time (28%).
* The average recipient age has stayed stable at 54 years in the last decade whereas the proportion of male recipients has decreased over years from 81% in 1992- 2000 to 76% in 2006- 2012.


==References==
==References==

Revision as of 19:17, 28 September 2014

Cardiac allograft vasculopathy Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Differentiating Cardiac allograft vasculopathy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

Coronary Angiography

Intravascular Ultrasound

Optical Coherence Tomography

CT

MRI

Echocardiography

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cardiac allograft vasculopathy epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cardiac allograft vasculopathy epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cardiac allograft vasculopathy epidemiology and demographics

CDC on Cardiac allograft vasculopathy epidemiology and demographics

Cardiac allograft vasculopathy epidemiology and demographics in the news

Blogs on Cardiac allograft vasculopathy epidemiology and demographics

Directions to Hospitals Treating Cardiac allograft vasculopathy

Risk calculators and risk factors for Cardiac allograft vasculopathy epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2]; Raviteja Guddeti, M.B.B.S. [3]

Overview

As per the data from the Registry of the International Society of Heart and Lung transplantation[1], the number of reported heart transplants has increased slowly in the recent years, especially in North America.

Epidemiology and Demographics

References

  1. ↑ Taylor DO, Edwards LB, Boucek MM, Trulock EP, Aurora P, Christie J; et al. (2007). "Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult heart transplant report--2007". J Heart Lung Transplant. 26 (8): 769–81. doi:10.1016/j.healun.2007.06.004. PMID 17692781.

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Cardiac_allograft_vasculopathy_epidemiology_and_demographics&oldid=1027382"